Fortress Biotech
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $16,066 | $17,631 | $16,413 | $13,139 |
Gross Profit | 10,639 | 11,876 | 11,474 | 8,349 |
EBITDA | -3,176 | 12,425 | -8,424 | -20,990 |
EBIT | -4,333 | 11,268 | -9,580 | -22,181 |
Net Income | -3,937 | 5,850 | 15,486 | -10,584 |
Net Change In Cash | 16,066 | 17,631 | 16,413 | 13,139 |
Free Cash Flow | -12,544 | -6,110 | -27,560 | -19,563 |
Cash | 79,381 | 86,218 | 74,386 | 91,339 |
Basic Shares | 279,018 | 33,100 | 29,824 | 26,450 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $63,262 | $57,675 | $84,513 | $75,743 |
Gross Profit | 42,338 | 36,796 | 61,620 | 44,968 |
EBITDA | -20,165 | -104,491 | -135,721 | -193,694 |
EBIT | -24,826 | -108,955 | -141,718 | -203,047 |
Net Income | 6,815 | -45,997 | -60,637 | -86,575 |
Net Change In Cash | 63,262 | 57,675 | 84,513 | 75,743 |
Free Cash Flow | -65,777 | -95,191 | -136,323 | -182,456 |
Cash | 79,381 | 57,263 | 80,927 | 178,266 |
Basic Shares | 279,018 | 20,784 | 8,111 | 5,925 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.21 |
2025-09-30 | $0.11 |
2025-06-30 | $0.45 |
2025-03-31 | -$0.48 |
